Literature DB >> 34526650

The newborn metabolome: associations with gestational diabetes, sex, gestation, birth mode, and birth weight.

David Burgner1,2,3, Richard Saffery4,5, Toby Mansell1,2, Amanda Vlahos1, Fiona Collier1,6,7, Anne-Louise Ponsonby1,2,8, Peter Vuillermin1,6,7, Susan Ellul1, Mimi L K Tang1,2,9.   

Abstract

BACKGROUND: Pathways towards many adult-onset conditions begin early in life, even in utero. Maternal health in pregnancy influences this process, but little is known how it affects neonatal metabolism. We investigated associations between pregnancy and birth factors and cord blood metabolomic profile in a large, population-derived cohort.
METHODS: Metabolites were measured using nuclear magnetic resonance in maternal (28 weeks gestation) and cord serum from 912 mother-child pairs in the Barwon Infant Study pre-birth cohort. Associations between maternal (metabolites, age, BMI, smoking), pregnancy (pre-eclampsia, gestational diabetes (GDM)), and birth characteristics (delivery mode, gestational age, weight, infant sex) with 72 cord blood metabolites were examined by linear regression.
RESULTS: Delivery mode, sex, gestational age, and birth weight were associated with specific metabolite levels in cord blood, including amino acids, fatty acids, and cholesterols. GDM was associated with higher cord blood levels of acetoacetate and 3-hydroxybutyrate.
CONCLUSIONS: Neonatal factors, particularly delivery mode, were associated with many cord blood metabolite differences, including those implicated in later risk of cardiometabolic disease. Associations between GDM and higher offspring ketone levels at birth are consistent with maternal ketosis in diabetic pregnancies. Further work is needed to determine whether these neonatal metabolome differences associate with later health outcomes. IMPACT: Variations in blood metabolomic profile have been linked to health status in adults and children, but corresponding data in neonates are scarce. We report evidence that pregnancy complications, mode of delivery, and offspring characteristics, including sex, are independently associated with a range of circulating metabolites at birth, including ketone bodies, amino acids, cholesterols, and inflammatory markers. Independent of birth weight, exposure to gestational diabetes is associated with higher cord blood ketone bodies and citrate. These findings suggest that pregnancy complications, mode of delivery, gestational age, and measures of growth influence metabolic pathways prior to birth, potentially impacting later health and development.
© 2021. The Author(s), under exclusive licence to the International Pediatric Research Foundation, Inc.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34526650     DOI: 10.1038/s41390-021-01672-7

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.953


  46 in total

Review 1.  Fetal origins of adult disease.

Authors:  Kara Calkins; Sherin U Devaskar
Journal:  Curr Probl Pediatr Adolesc Health Care       Date:  2011-07

Review 2.  Inflammation, infection and atherosclerosis.

Authors:  Prediman K Shah
Journal:  Trends Cardiovasc Med       Date:  2019-01-28       Impact factor: 6.677

3.  Investigation of the impact of birth by cesarean section on fetal and maternal metabolism.

Authors:  Engy Shokry; Linda Marchioro; Olaf Uhl; Mercedes G Bermúdez; Jose Antonio García-Santos; Mª Teresa Segura; Cristina Campoy; Berthold Koletzko
Journal:  Arch Gynecol Obstet       Date:  2019-06-14       Impact factor: 2.344

4.  Female and male human babies have distinct blood metabolomic patterns.

Authors:  Margherita Ruoppolo; Emanuela Scolamiero; Marianna Caterino; Valentina Mirisola; Flavia Franconi; Ilaria Campesi
Journal:  Mol Biosyst       Date:  2015-07-03

5.  High-throughput quantification of circulating metabolites improves prediction of subclinical atherosclerosis.

Authors:  Peter Würtz; Juho R Raiko; Costan G Magnussen; Pasi Soininen; Antti J Kangas; Tuulia Tynkkynen; Russell Thomson; Reino Laatikainen; Markku J Savolainen; Jari Laurikka; Pekka Kuukasjärvi; Matti Tarkka; Pekka J Karhunen; Antti Jula; Jorma S Viikari; Mika Kähönen; Terho Lehtimäki; Markus Juonala; Mika Ala-Korpela; Olli T Raitakari
Journal:  Eur Heart J       Date:  2012-03-26       Impact factor: 29.983

Review 6.  Early atherosclerosis in humans: role of diffuse intimal thickening and extracellular matrix proteoglycans.

Authors:  Yutaka Nakashima; Thomas N Wight; Katsuo Sueishi
Journal:  Cardiovasc Res       Date:  2008-04-22       Impact factor: 10.787

7.  Metabolomic profile of term infants of gestational diabetic mothers.

Authors:  Carlo Dani; Cecilia Bresci; Elettra Berti; Serena Ottanelli; Giorgio Mello; Federico Mecacci; Rita Breschi; Xiaoyu Hu; Leonardo Tenori; Claudio Luchinat
Journal:  J Matern Fetal Neonatal Med       Date:  2013-09-12

8.  Maternal BMI and Glycemia Impact the Fetal Metabolome.

Authors:  William L Lowe; James R Bain; Michael Nodzenski; Anna C Reisetter; Michael J Muehlbauer; Robert D Stevens; Olga R Ilkayeva; Lynn P Lowe; Boyd E Metzger; Christopher B Newgard; Denise M Scholtens
Journal:  Diabetes Care       Date:  2017-07       Impact factor: 19.112

9.  Serum metabolites and risk of myocardial infarction and ischemic stroke: a targeted metabolomic approach in two German prospective cohorts.

Authors:  Anna Floegel; Tilman Kühn; Disorn Sookthai; Theron Johnson; Cornelia Prehn; Ulrike Rolle-Kampczyk; Wolfgang Otto; Cornelia Weikert; Thomas Illig; Martin von Bergen; Jerzy Adamski; Heiner Boeing; Rudolf Kaaks; Tobias Pischon
Journal:  Eur J Epidemiol       Date:  2017-11-27       Impact factor: 8.082

10.  Serum metabolic signatures of coronary and carotid atherosclerosis and subsequent cardiovascular disease.

Authors:  Ioanna Tzoulaki; Raphaële Castagné; Claire L Boulangé; Ibrahim Karaman; Elena Chekmeneva; Evangelos Evangelou; Timothy M D Ebbels; Manuja R Kaluarachchi; Marc Chadeau-Hyam; David Mosen; Abbas Dehghan; Alireza Moayyeri; Diana L Santos Ferreira; Xiuqing Guo; Jerome I Rotter; Kent D Taylor; Maryam Kavousi; Paul S de Vries; Benjamin Lehne; Marie Loh; Albert Hofman; Jeremy K Nicholson; John Chambers; Christian Gieger; Elaine Holmes; Russell Tracy; Jaspal Kooner; Philip Greenland; Oscar H Franco; David Herrington; John C Lindon; Paul Elliott
Journal:  Eur Heart J       Date:  2019-09-07       Impact factor: 29.983

View more
  5 in total

1.  Early life infection and proinflammatory, atherogenic metabolomic and lipidomic profiles in infancy: a population-based cohort study.

Authors:  Toby Mansell; Richard Saffery; Satvika Burugupalli; Anne-Louise Ponsonby; Mimi L K Tang; Martin O'Hely; Siroon Bekkering; Adam Alexander T Smith; Rebecca Rowland; Sarath Ranganathan; Peter D Sly; Peter Vuillermin; Fiona Collier; Peter Meikle; David Burgner
Journal:  Elife       Date:  2022-05-10       Impact factor: 8.713

2.  Urinary Metabolomic Profile of Neonates Born to Women with Gestational Diabetes Mellitus.

Authors:  Ana Sofía Herrera-Van Oostdam; Mariana Salgado-Bustamante; Victoria Lima-Rogel; Juan José Oropeza-Valdez; Jesús Adrián López; Iván Daniel Román Rodríguez; Juan Carlos Toro-Ortiz; David Alejandro Herrera-Van Oostdam; Yamilé López-Hernández; Joel Monárrez-Espino
Journal:  Metabolites       Date:  2021-10-22

3.  Metabolomics Applied to Cord Serum in Preeclampsia Newborns: Implications for Neonatal Outcomes.

Authors:  Xiaoxu Wang; Jieying Liu; Xiangyi Hui; Yingna Song
Journal:  Front Pediatr       Date:  2022-04-25       Impact factor: 3.569

Review 4.  Metabolomics of Breast Cancer: A Review.

Authors:  Ramadevi Subramani; Seeta Poudel; Kenneth D Smith; Adriana Estrada; Rajkumar Lakshmanaswamy
Journal:  Metabolites       Date:  2022-07-13

5.  Sex-Dependent Regulation of Placental Oleic Acid and Palmitic Acid Metabolism by Maternal Glycemia and Associations with Birthweight.

Authors:  Oliver C Watkins; Hannah E J Yong; Tania Ken Lin Mah; Victoria K B Cracknell-Hazra; Reshma Appukuttan Pillai; Preben Selvam; Neha Sharma; Amaury Cazenave-Gassiot; Anne K Bendt; Keith M Godfrey; Rohan M Lewis; Markus R Wenk; Shiao-Yng Chan
Journal:  Int J Mol Sci       Date:  2022-08-04       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.